STOCK TITAN

Immuron (IMRN) Revenue by Year

IMRN NASDAQ

Immuron Limited generated $4.8M in revenue in fiscal year 2025. This represents an increase of 46.3% from the prior fiscal year. The table below carries 10 fiscal years, from 2016 to 2025, and the quarters Immuron Limited has filed alongside them.

FY2025 annual
Revenue $4.8M
YoY +46.3%
5Y CAGR +22.5%
Source SEC Filings (20-F/6-K) Latest period FY2025, ended Jun 30, 2025 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

IMRN Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2520-FFY2420-FFY2320-FFY2220-FFY2120-FFY2020-FFY1920-FFY1820-FFY1720-FFY1620-F
Revenue$4.8M+46.3%$3.3M+172.2%$1.2M+127.6%$528K+383.5%$109K-93.7%$1.7M+22.9%$1.4M+31.1%$1.1M+0.6%$1.1M+44.0%$744K

IMRN Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ4'2520-FQ4'2420-FQ2'246-KQ4'2320-FQ2'236-KQ4'2220-FQ4'2120-FQ4'2020-FQ2'206-KQ4'1920-FQ2'196-KQ4'1820-F
RevenueN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More Immuron Limited financials

Frequently Asked Questions

What was Immuron Limited's revenue in fiscal year 2025?

Immuron Limited generated $4.8M in revenue in fiscal year 2025.

How fast is Immuron Limited's revenue growing?

Immuron Limited (IMRN) revenue rose by 46.3% year over year, from $3.3M to $4.8M in fiscal year 2025.

How has Immuron Limited's revenue changed over the years?

Across the 10 fiscal years this page covers, Immuron Limited (IMRN) revenue went from $744K in fiscal year 2016 to $4.8M in fiscal year 2025.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Immuron Limited (IMRN) reported on that line in every period on record.